Average Co-Inventor Count = 2.22
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. New York University (7 from 1,624 patents)
2. Benevir Biopharm, Inc. (5 from 5 patents)
3. Sequella, Inc. (2 from 9 patents)
10 patents:
1. 11147846 - Oncolytic herpes simplex virus and therapeutic uses thereof
2. 10456432 - Oncolytic herpes simplex virus and therapeutic uses thereof
3. 10232003 - Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof
4. 10105404 - Oncolytic herpes simplex virus and therapeutic uses thereof
5. 9623059 - Oncolytic herpes simplex virus and therapeutic uses thereof
6. 8709397 - Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
7. 8501400 - Methods and compositions for determining the pathogenic status of infectious agents
8. 8252277 - Virulent oncolytic herpes simplex virus strains engineered to counter the innate host response
9. 7919234 - Methods and compositions for determining the pathogenic status of infectious agents
10. 7731952 - Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response